Company facts
- Headquarters
- Redwood City, California
- Most recent report
- 10-Q, filed Aug 5, 2026
- Incorporated
- Delaware
- Filings on record
- 818 filings
- On EDGAR
- CIK 1628171
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 27
News 8 of 69
Prospectuses and Registrations 8 of 37
- 424B5 Prospectus supplement for an offering Apr 15, 2026
- 424B5 Prospectus supplement for an offering Apr 15, 2026
- FWP Free writing prospectus Apr 15, 2026
- 424B5 Prospectus supplement for an offering Apr 13, 2026
- 424B5 Prospectus supplement for an offering Apr 13, 2026
- 424B5 Prospectus supplement for an offering Feb 25, 2026
- S-8 Registration statement for an employee plan Feb 25, 2026
- S-8 Registration statement for an employee plan Feb 26, 2025
Proxies 8 of 15
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Apr 25, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2024
- DEFA14A Extra proxy material Nov 1, 2023
- DEFM14A Sep 29, 2023
Ownership 8 of 615
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 13, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 29, 2026
- 4 Insider reported a trade Jul 1, 2026
- 144 Notice of a proposed sale of restricted stock Jun 29, 2026
- 4 Insider reported a trade Jun 26, 2026
- 144 Notice of a proposed sale of restricted stock Jun 24, 2026
Other 8 of 55
- ARS Annual report sent to shareholders Apr 28, 2026
- 305B2 Apr 15, 2026
- ARS Annual report sent to shareholders Apr 29, 2025
- UPLOAD Comment letter from SEC staff Apr 26, 2024
- ARS Annual report sent to shareholders Apr 25, 2024
- CORRESP Reply to SEC staff Apr 19, 2024
- UPLOAD Comment letter from SEC staff Apr 9, 2024
- CERT Exchange certified a listing Nov 16, 2023
Everything here comes from Revolution Medicines, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.